EverSource Wealth Advisors’s Coherus Oncology CHRS Stock Holding History

EverSource Wealth Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.71K	Buy
2025 Q1	$1.29K	Buy
2024 Q4	$1.76K	Buy